Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria C Ramos

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Scientific Reports|August 16, 2024
Identification of novel small molecule-based strategies of COL7A1 upregulation and readthrough activity for the treatment of recessive dystrophic epidermolysis bullosaIrene Jover, Maria C Ramos, María José Escámez, et al.
Iscience|May 19, 2025
Morphological profiling data resource enables prediction of chemical compound propertiesChristopher Wolff, Martin Neuenschwander, Carsten Jörn Beese, et al.
Journal of Medicinal Chemistry|January 12, 2023
Discovery and Hit-to-Lead Optimization of Benzothiazole Scaffold-Based DNA Gyrase Inhibitors with Potent Activity against <i>Acinetobacter baumannii</i> and <i>Pseudomonas aeruginosa</i>Andrej Emanuel Cotman, Martina Durcik, Davide Benedetto Tiz, et al.
Journal of Medicinal Chemistry|March 6, 2023
New Dual Inhibitors of Bacterial Topoisomerases with Broad-Spectrum Antibacterial Activity and In Vivo Efficacy against Vancomycin-Intermediate <i>Staphylococcus aureus</i>Martina Durcik, Andrej Emanuel Cotman, Žan Toplak, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Scientific Reports|August 16, 2024
Identification of novel small molecule-based strategies of COL7A1 upregulation and readthrough activity for the treatment of recessive dystrophic epidermolysis bullosaIrene Jover, Maria C Ramos, María José Escámez, et al.
Iscience|May 19, 2025
Morphological profiling data resource enables prediction of chemical compound propertiesChristopher Wolff, Martin Neuenschwander, Carsten Jörn Beese, et al.
Journal of Medicinal Chemistry|January 12, 2023
Discovery and Hit-to-Lead Optimization of Benzothiazole Scaffold-Based DNA Gyrase Inhibitors with Potent Activity against <i>Acinetobacter baumannii</i> and <i>Pseudomonas aeruginosa</i>Andrej Emanuel Cotman, Martina Durcik, Davide Benedetto Tiz, et al.
Journal of Medicinal Chemistry|March 6, 2023
New Dual Inhibitors of Bacterial Topoisomerases with Broad-Spectrum Antibacterial Activity and In Vivo Efficacy against Vancomycin-Intermediate <i>Staphylococcus aureus</i>Martina Durcik, Andrej Emanuel Cotman, Žan Toplak, et al.
Pageof 4